Post Polycythemia Vera Myelofibrosis Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
Recruiting
  • Myelofibrosis
  • +3 more
  • Anchorage, Alaska
  • +155 more
2022-04-06
Apr 6, 2022
N
CINC424A2X01B Rollover Protocol
Recruiting
  • Primary Myelofibrosis
  • +4 more
  • ruxolitinib tablets or oral pediatric formulation, panobinostat capsules
  • ruxolitinib tablets or oral pediatric formulation
  • Darlinghurst, New South Wales, Australia
  • +96 more
2022-03-29
Mar 29, 2022
I
To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)
Recruiting
  • Myelofibrosis
  • +3 more
  • Berkeley, California
  • +178 more
2022-03-22
Mar 22, 2022
J
Ruxolitinib Prior to Transplant in Patients With Myelofibrosis - 2017
Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Ruxolitinib Pre- Hematopoietic cell transplantation (HCT)
  • Atlanta, Georgia
  • +7 more
2019-02-28
Feb 28, 2019